Home/Filings/4/0001209191-14-000751
4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-14-000751

$TCRTCIK 0001107421operating

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 3:44 PM ET

Size

7.1 KB

Accession

0001209191-14-000751

Insider Transaction Report

Form 4
Period: 2013-12-31
LEWIS JONATHAN
DirectorCEO
Transactions
  • Tax Payment

    Common Stock

    2013-12-31$4.34/sh15,023$65,200509,753 total
  • Award

    Employee Stock Option (Right to Buy)

    2013-12-31+300,000300,000 total
    Exercise: $4.34Exp: 2023-12-31Common Stock (300,000 underlying)
Footnotes (2)
  • [F1]Representes shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
  • [F2]100,000 shares vest on each of 12/31/2014; 12/31/2015 and 12/31/2016.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001107421

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:44 PM ET
Size
7.1 KB